18-02-2025, 18:00

Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)

Notified -
Globe Newswire18-02-2025, 18:00
13-01-2025, 13:00

Teva Announces Collaboration to Commercialize Formycon’s Biosimilar Candidate to Eylea® (aflibercept) in major parts of Europe and in Israel

Notified -
Globe Newswire13-01-2025, 13:00
15-11-2024, 13:00

Sandoz receives European Commission approval for Afqlir® (aflibercept), further strengthening leading biosimilar portfolio
Globe Newswire15-11-2024, 13:00
12-08-2024, 12:00

Sandoz receives FDA approval for Enzeevu™ (aflibercept-abzv), further strengthening US biosimilar position
Globe Newswire12-08-2024, 12:00